콘텐츠로 건너뛰기
Merck
  • Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

FEBS letters (2015-06-23)
Rika Nishikawa, Takeshi Chiyomaru, Hideki Enokida, Satoru Inoguchi, Tomoaki Ishihara, Ryosuke Matsushita, Yusuke Goto, Ichiro Fukumoto, Masayuki Nakagawa, Naohiko Seki
초록

Here, we found that members of the microRNA-29 family (miR-29a/b/c; "miR-29s") were significantly reduced in clear cell renal cell carcinoma (ccRCC) tissues, suggesting that they functioned as tumour suppressors. Restoration of all mature members of the miR-29 family inhibited cancer cell proliferation, migration and invasion. LOXL2 was a direct target gene of miR-29s, as shown by genome-wide gene expression analysis and luciferase reporter assay. Overexpressed LOXL2 was confirmed in ccRCC clinical specimens, and silencing of LOXL2 inhibited cancer cell migration and invasion in ccRCC cell lines. Our data demonstrated that the miR-29s-LOXL2 axis contributed to cancer cell migration and invasion in ccRCC.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Lysyl Oxidase-like 2 (LOXL2) FLAG-tag (Sf9-derived) human, recombinant, expressed in baculovirus infected insect cells, ≥65% (SDS-PAGE)